September 27, 2016 10:40 PM ET


Company Overview of Oscient Pharmaceuticals Corp.

Company Overview

As of June 30, 2010, Oscient Pharmaceuticals Corp. went out of business. Oscient Pharmaceuticals Corporation, a commercial-stage pharmaceutical company, sells and markets products to primary care physicians, cardiologists, endocrinologists, and pulmonologists in the United States. It markets ANTARA (fenofibrate) capsules, a cardiovascular product for the adjunct treatment of hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with diet; and FACTIVE (gemifloxacin mesylate) tablets, a fluoroquinolone antibiotic for the treatment of acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia of mild to moderate seve...

1000 Winter Street

Suite 2200

Waltham, MA 02451

United States

Founded in 1961

316 Employees





Key Executives for Oscient Pharmaceuticals Corp.

Oscient Pharmaceuticals Corp. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oscient Pharmaceuticals Corp., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at